Updated 6/13/2022: NYSDOH Guidance for COVID-19 Ages 12+

Updated 6/13/2022: NYSDOH Guidance for COVID-19 Ages 12+

June 14th, 2022 | VaccineNewsCOVID-19

A summary of the most recent changes to the attached Guidance for the New York State COVID-19 Vaccination Program for Individuals 12 Years of Age and Older is outlined below:

  • CDC clinical considerations were amended to state that the following people should receive a second COVID-19 booster dose: (1) people ages 12 years and older who are moderately to severely immunocompromised, and (2) people ages 50 years and older.   
  • CDC clinical considerations were amended to provide considerations for
    Loader Loading...
    EAD Logo Taking too long?

    Reload Reload document
    | Open Open in new tab

    Download PDF [422.16 KB]

    people who recently had SARS-CoV-2 infection to delay their primary series or booster doses by 3 months from symptom onset or positive test (if infection was asymptomatic).  
  • The CDC has updated clinical considerations for COVID-19 re-vaccination for patients who received one or more doses of COVID-19 vaccine during treatment with B-cell depleting therapies (e.g., rituximab, ocrelizumab) that were administered over a limited period of time.
  • Clarifying updates were made regarding the considerations to initiate COVID-19 vaccination in individuals with a history of multisystem inflammatory syndrome (MIS-C and MIS-A).
  • The FDA Emergency Use Authorization for Janssen COVID-19 vaccine has now been limited in use to specific situations. COVID-19 vaccine recipients should be informed that mRNA COVID-19 vaccines are preferred over the Janssen COVID-19 vaccine.
  • Updates were made regarding individuals who were vaccinated outside the US and individuals who were vaccinated as part of a clinical trial.